Pharmaceuticals

ALTERNATIVE LABELS
Medication
Pharmaceutical industry
Report

The new frontier - delivering better health for all Australians

This report examines the opportunities to deliver better health care for Australians through our regulatory and health technology assessment process for both medicines and technologies.
Report

Funding rare disease therapies in Australia: 2021 progress update

For the 2 million Australians living with rare diseases, access to medicines can be inadequate. This report reassesses 2014 research by the McKell Institute, assessing the state of rare disease therapies in Australia.
Report

COVID-19 procurements and deployments of the National Medical Stockpile

This audit is one of five performance audits conducted under phase one of the ANAO’s multi-year strategy that focuses on the effective, efficient, economical and ethical delivery of the Australian Government’s response to the COVID-19 pandemic, and the second of two performance audits focused on...
Guide

The science of immunisation: questions and answers

This guide, developed in partnership with the federal Department of Health, answers common questions about immunisation.
Report

Planning and governance of COVID-19 procurements to increase the National Medical Stockpile

This audit examined whether the COVID-19 National Medical Stockpile (NMS) procurement requirement was met through effective planning and governance arrangements.
Report

Patient power: unleashing choice over routine medications

This report finds that many patients are not fully aware of the level of control they are entitled to when it comes to choosing medication. It suggests that pharmacists could play a greater role in the patient care pathway to support patients make choices about...
Report

Rationalising regulation: helping the economy recover from the corona crisis

Australia’s anachronistic, inconsistent and excessive regulatory landscape is an area of immense potential for growth-enhancing economic reforms. This paper considers regulations across a wide range of sectors, including the construction, agricultural, pharmaceutical, retail trade, mining, hospitality and tourism, and childcare sectors.
Report

Biodata and biotechnology: opportunity and challenges for Australia

This report canvasses the extraordinary recent developments in genome sequencing and genetic engineering, which will transform all biological enterprises, including healthcare, among the most important parts of the global economy. It argues that there is a opportunity for Australia to play a leading role in...
Fact sheet

Fact Check Fact File: The history of vaccines, from smallpox to SARS and beyond

With the world focused on a fast-tracked treatment for the novel coronavirus, RMIT ABC Fact Check takes a look at the history of vaccine development in the fight against some of the world's most infectious diseases.
Report

COVID-19 disinformation and social media manipulation: pro-Russian vaccine politics drives new disinformation narratives

This latest report in the series on COVID-19 disinformation and social media manipulation investigates vaccine disinformation emerging – the day after Russia announced plans to mass-produce its own vaccine - from Eastern Ukraine’s pro-Russian media ecosystem.
Fact sheet

Fact Check: Clive Palmer says hydroxychloroquine contributed to Australia's low COVID-19 death rate. Is he correct?

Businessman and former federal MP Clive Palmer claimed that use of the anti-malarial drug hydroxychloroquine contributed to Australia’s low death rate during the coronavirus pandemic. He said the Covid-19 death curve had flattened after the federal health minister announced the drug would be made available...
Report

National Drug Strategy household survey 2019

This report presents key results from the 2019 National Drug Strategy household survey. It looks at people’s drug use throughout their lives and during the last 12 months, and examines how these patterns have changed over time.
Fact sheet

Fact Check: Threat to the survival of local pharmacies exaggerated

The Pharmacy Guild of Australia claims that bringing forward reductions in the prices of prescription medicines will threaten the survival of local pharmacies.
Fact sheet

Fact Check: How much is subsidising cheap paracetamol costing the government?

Health Minister Sussan Ley claims subsidising paracetamol that can be bought cheaply without a prescription is costing the government $73 million a year.
Briefing paper

The most promising therapeutics for COVID-19

This rapid research brief responds to the question - what are the most promising COVID-19 therapeutics in development globally and nationally, and what are their mechanisms of action, their stage of development and their strengths and limitations?
Briefing paper

The most promising vaccines for COVID-19

This rapid research brief responds to the question - what are the most promising vaccines in development globally and nationally, and what are their mechanisms of action, their stage of development and their strengths and limitations?
Report

Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16

In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. The objective of this report was to estimate the social costs arising from extra-medical opioid use in Australia for the...
Report

Availability of COVID-19 related products on Tor darknet markets

Tor darknet markets are frequently used as a litmus test of illicit drug and malware trends, as well as criminal novelty and entrepreneurship more generally. Crime follows opportunity and the COVID-19 pandemic offers profiteering arising from shortages and fear.
Report

Is there fentanyl contamination in the Australian illicit drug market?

This research investigates fentanyl use among police detainees participating in the Drug Use Monitoring in Australia program.
Report

The social supply of pharmaceutical opioids

This study explores the prevalence, predictors and nature of the ‘social supply’ of pharmaceutical opioids among police detainees.